In Vitro Maturation of Human Oocytes

The use of IVM in assisted reproductive technology continues to increase around the world. The major benefit of IVM is that significant numbers of oocytes can be collected from ovaries without recourse to ovarian stimulation. This reduces the costs, time, and risks associated with conventional IVF. Although initially limited to women with polycystic ovary syndrome who were at higher risk of problems following ovarian stimulation, IVM is increasingly used in women with normal ovulatory menstrual cycles. This authoritative text covers the current scientific knowledge of oocyte development and the understanding behind the techniques involved in the clinical application of IVM in assisted reproductive technologies. Short Contents

Seang Lin Tan MBBS FRCOG FRCSC FACOG MMed (O&G) MBA, James Edmund Dodds Professor and Chair, Department of Obstetrics and Gynecology, McGill University, Obstetrician and Gynecologist in Chief, McGill University Health Centre, Medical Director, McGill Reproductive Centre, Montreal QC, Canada. Ri-Cheng Chian MSC PhD, Scientific Director, McGill Reproductive Centre ,Assistant Professor, Department of Obstetrics and Gynecology, McGill University Royal Victoria Hospital, Montreal QC, Canada. William M Buckett MB chB MD MRCOG, Assistant Professor, Department of Obstetrics and Gynecology, McGill University Royal Victoria Hospital, Montreal, QC, Canada.